| |
| |
|
| Insider
Information: |
Dawes Karen A |
| Relationship: |
Director |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
176,709 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,185,548 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
176,709 |
|
|
| Total
Value |
$13,185,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 10.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
Chairperson of the Boa... |
2008-04-29 |
2,250 |
2005-05-24 |
0 |
Premium* |
|
|
Repligen Corp |
RGEN |
|
2024-05-16 |
88,170 |
2006-09-01 |
0 |
Premium* |
|
|
Assertio Holdings Inc |
ASRT |
Director |
2020-05-08 |
84,589 |
2008-12-01 |
0 |
Premium* |
|
|
Vaccitech Plc |
VACC |
Director |
2021-05-04 |
1,700 |
2021-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGEN |
Repligen Corp |
Director |
– • – |
2021-08-17 |
4 |
AS |
$251.15 |
$4,444,561 |
D/D |
(17,514) |
95,363 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2022-05-25 |
4 |
AS |
$149.18 |
$2,214,819 |
D/D |
(14,715) |
76,532 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2020-06-18 |
4 |
AS |
$113.58 |
$2,154,851 |
D/D |
(18,705) |
100,734 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2020-04-20 |
4 |
AS |
$104.42 |
$1,275,717 |
D/D |
(12,200) |
109,034 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-11-10 |
4 |
AS |
$259.75 |
$1,262,355 |
D/D |
(4,783) |
91,247 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-09-01 |
4 |
AS |
$280.27 |
$982,058 |
D/D |
(3,459) |
93,921 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-07-20 |
4 |
AS |
$200.01 |
$926,605 |
D/D |
(4,585) |
112,877 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2018-05-11 |
4 |
S |
$41.80 |
$835,936 |
D/D |
(20,000) |
94,957 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-11-02 |
4 |
AS |
$299.02 |
$729,467 |
D/D |
(2,400) |
91,247 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2020-02-21 |
4 |
S |
$97.52 |
$394,793 |
D/D |
(4,000) |
113,034 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-08-18 |
4 |
AS |
$257.66 |
$363,166 |
D/D |
(1,402) |
93,961 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-07-13 |
4/A |
AS |
$201.27 |
$307,395 |
D/D |
(1,520) |
117,462 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-07-13 |
4 |
S |
$202.23 |
$307,390 |
D/D |
(1,520) |
117,462 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2020-05-18 |
4 |
AS |
$135.76 |
$220,448 |
D/D |
(1,600) |
119,956 |
0 |
% |
|
| RGEN |
Repligen Corp |
|
– • – |
2024-02-27 |
4 |
OE |
$42.07 |
$194,616 |
D/D |
4,626 |
88,367 |
0 |
- |
|
| RGEN |
Repligen Corp |
|
– • – |
2024-02-27 |
4 |
S |
$193.35 |
$193,350 |
D/D |
(1,000) |
87,367 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2022-09-09 |
4 |
S |
$227.17 |
$176,057 |
D/D |
(775) |
76,401 |
0 |
% |
|
| RGEN |
Repligen Corp |
|
– • – |
2023-08-29 |
4 |
S |
$171.38 |
$145,673 |
D/D |
(850) |
83,741 |
0 |
% |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-09-01 |
4 |
OE |
$38.76 |
$134,071 |
D/D |
3,459 |
97,380 |
0 |
- |
|
| RGEN |
Repligen Corp |
|
– • – |
2023-08-29 |
4 |
OE |
$18.12 |
$133,943 |
D/D |
7,392 |
84,591 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-11-10 |
4 |
OE |
$26.12 |
$124,932 |
D/D |
4,783 |
96,030 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2021-07-13 |
4 |
OE |
$41.19 |
$120,646 |
D/D |
2,929 |
118,982 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2018-05-11 |
4 |
OE |
$5.08 |
$101,600 |
D/D |
20,000 |
114,957 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2019-06-17 |
4 |
S |
$77.35 |
$100,168 |
D/D |
(1,295) |
117,034 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2019-06-17 |
4 |
OE |
$4.96 |
$99,200 |
D/D |
20,000 |
118,329 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
